Thank you, Mr. Chair.
I want to thank all the witnesses for their testimony.
My first set of questions are for Dr. MacDonald.
Thank you for your comments on the need for clearer timelines and accountability in order to prevent multi-year delays and provide certainty.
I want to start by asking you about the recommendation on safer substitution. Can you explain to the committee what is meant by “safer substitution” and how this could be integrated into CEPA?